Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer.

Saved in:
Bibliographic Details
Title: Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer.
Authors: Styrke J; Department of Diagnostics and Intervention, Urology and Andrology, Umeå University, Umeå, Sweden. johan.styrke@umu.se., Jellvert Å; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgery, Region Västra Götaland, NU Hospital Group, Uddevalla, Sweden., Hjälm Eriksson M; Department of Surgery and Oncology, Capio St. Görans Hospital, Karolinska Institute, Department of Pathology and Oncology, Stockholm, Sweden., Sandin F; Regional Cancer Centre, Mid Sweden, Uppsala, Sweden., Axén E; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden., Jabbar S; Astellas Pharma A/S, Copenhagen, Denmark., Juhl Norgaard K; Astellas Pharma A/S, Copenhagen, Denmark.
Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2026 May 21; Vol. 65, pp. 449-459. Date of Electronic Publication: 2026 May 21.
Publication Type: Journal Article
Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1651-226X
DOI:10.2340/1651-226X.2026.45110